Management of Coronary Disease in Patients with Advanced Kidney Disease

RCT (n=777) reports no difference in primary outcome (composite of death or nonfatal MI) between those undergoing revascularisation via an invasive strategy vs those managed medically: estimated 3-year event rate, 36.4% vs. 36.7%; HR 1.01; 95% CI, 0.79 to 1.29; P=0.95)

SPS commentary:

In a related editorial, authors note that important advances have occurred in both strategies, leading to equipoise as to which approach is preferable for patients with stable ischaemic heart disease.


New England Journal of Medicine

Resource links:

Link to editorial